A new study has identified a novel molecular pathway underlying Parkinson's disease and points to existing drugs which may be able to slow progression of the disease. The pathway involved proteins -- known as polyamines -- that were found to be responsible for the increase in build-up of other toxic proteins in neurons, which causes the neurons to malfunction and, eventually, die.